Mir Hashim
Chief Tech/Sci/R&D Officer presso RANI THERAPEUTICS HOLDINGS, INC.
Patrimonio netto: 4 M $ in data 31/03/2024
Profilo
Mir Hashim is currently the Chief Scientific Officer & Director at Rani Therapeutics LLC.
He is also the Vice President-Research & Development at InCube Labs LLC since 2008.
Additionally, Dr. Hashim holds the position of Chief Scientific Officer at Rani Therapeutics Holdings, Inc. since 2021.
Previously, he worked as the Head-Pharmacology at GSK Plc.
Dr. Hashim holds a doctorate degree from Memorial University of Newfoundland, an undergraduate degree from Osmania University, and a graduate degree from the University of Hyderabad.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
Rani Therapeutics LLC
 Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. 2.55% | 29/07/2021 | 786 392 ( 2.55% ) | 2 M $ | 31/03/2024 |
| 31/03/2023 | 374 119 ( inf% ) | 1 M $ | 31/03/2024 | |
| 21/03/2024 | 44 565 ( 0.17% ) | 138 597 $ | 31/03/2024 | |
| 31/03/2023 | 25 649 ( 0.09% ) | 79 768 $ | 31/03/2024 |
Posizioni attive di Mir Hashim
| Società | Posizione | Inizio |
|---|---|---|
| RANI THERAPEUTICS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 06/04/2021 |
Rani Therapeutics LLC
Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | Chief Tech/Sci/R&D Officer | - |
InCube Labs LLC
 InCube Labs LLC Medical SpecialtiesHealth Technology InCube Labs LLC provides therapeutic services and medical devices. It offers treatment to central nervous system, cardiovascular disease, metabolic diseases, micronutrient deficiency, and gastrointestinal end-stage renal disease cancer. The company was founded on February 22, 2007 and is headquartered in San Jose, CA. | Chief Tech/Sci/R&D Officer | 01/09/2008 |
Precedenti posizioni note di Mir Hashim
| Società | Posizione | Fine |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | - |
Formazione di Mir Hashim
| Memorial University of Newfoundland | Doctorate Degree |
| Osmania University | Undergraduate Degree |
| University of Hyderabad | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GSK PLC | Health Technology |
| Aziende private | 3 |
|---|---|
Rani Therapeutics LLC
Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | Health Technology |
| Rani Therapeutics Holdings, Inc. | |
InCube Labs LLC
InCube Labs LLC Medical SpecialtiesHealth Technology InCube Labs LLC provides therapeutic services and medical devices. It offers treatment to central nervous system, cardiovascular disease, metabolic diseases, micronutrient deficiency, and gastrointestinal end-stage renal disease cancer. The company was founded on February 22, 2007 and is headquartered in San Jose, CA. | Health Technology |
- Borsa valori
- Insiders
- Mir Hashim
